Pasar al contenido principal

NUEVOS FARMACOS INHIBIDORES DE CARBAPENEMASAS. DESCUBRIMIENTO DE COMPUESTOS MEDIANTE DISEÑO ESTRUCTURAL.

PID2021-126625OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

  • Oltra Sanchis, Sara
  • Albanell Mestres, Joan
  • Moreno-Bueno, Gema
Gasdermin (GSDM)-mediated pyroptosis is functionally involved in multiple diseases, but Gasdermin-B (GSDMB) exhibit cell death-dependent and independent activities in several pathologies including cancer. When the GSDMB pore-forming N-terminal domain is released by Granzyme-A cleavage, it provokes cancer cell death, but uncleaved GSDMB promotes multiple pro-tumoral effects (invasion, metastasis, and drug resistance). To uncover the mechanisms of GSDMB pyroptosis, here we determined the GSDMB regions essential for cell death and described for the first time a differential role of the four translated GSDMB isoforms (GSDMB1-4, that differ in the alternative usage of exons 6-7) in this process. Accordingly, we here prove that exon 6 translation is essential for GSDMB mediated pyroptosis, and therefore, GSDMB isoforms lacking this exon (GSDMB1-2) cannot provoke cancer cell death. Consistently, in breast carcinomas the expression of GSDMB2, and not exon 6-containing variants (GSDMB3-4), associates with unfavourable clinical-pathological parameters. Mechanistically, we show that GSDMB N-terminal constructs containing exon-6 provoke cell membrane lysis and a concomitant mitochondrial damage. Moreover, we have identified specific residues within exon 6 and other regions of the N-terminal domain that are important for GSDMB-triggered cell death as well as for mitochondrial impairment. Additionally, we demonstrated that GSDMB cleavage by specific proteases (Granzyme-A, Neutrophil Elastase and caspases) have different effects on pyroptosis regulation. Thus, immunocyte-derived Granzyme-A can cleave all GSDMB isoforms, but in only those containing exon 6, this processing results in pyroptosis induction. By contrast, the cleavage of GSDMB isoforms by Neutrophil Elastase or caspases produces short N-terminal fragments with no cytotoxic activity, thus suggesting that these proteases act as inhibitory mechanisms of pyroptosis. Summarizing, our results have important implications for understanding the complex roles of GSDMB isoforms in cancer or other pathologies and for the future design of GSDMB-targeted therapies., This study has been supported by the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MICINN-AEI, PID2019-104644RB-I00, PDC2022-133252-I00) -GMB-, (PID2021-126625OB-I00-MCIN/AEI/10.13039/501100011033 FEDER, EU.2022- and DTS20-00024 -ISCIII-) -PGP-, the Instituto de Salud Carlos III (CIBERONC, CB16/12/00295 -GMB- and CB16/12/00241 -JA-, and AC21_2/00020 ERA PerMed ERA-NET, PMP22/00054 Immune4ALL Personalized Medicine -GMB-, cofunded by NextGenerationEU), I “Semilla” CIBERONC-GEICAM Grant -GMB- and the AECC Scientific Foundation (FCAECC PROYE19036MOR and GCTRA18014MATI -GMB-), the National Institutes of Health (NIH, USA) (R01-DK123475) -J-KK- and it has been also supported by a startup fund to -J-KK- from the Ohio State University, the College of Medicine, Department of Surgery. DS contract is funded by CIBERONC partly supported by FEDER funds. SO is funded by the FCAECC (POSTD20028OLTR), SC is funded by the MICINN-AEI PRE2020-095658.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

  • Oltra, Sara S.
  • Colomo, Sara
  • Sin, Laura
  • Pérez-López, María
  • Lázaro, Sara
  • Molina-Crespo, Ángela
  • Choi, Kyoung-Han
  • Ros-Pardo, David
  • Martínez, Lidia
  • Morales, Saleta
  • González-Paramos, Cristina
  • Orantes, Alba
  • Soriano, Mario
  • Hernández, Alberto
  • Lluch, Ana
  • Rojo, Federico
  • Albanell, Joan
  • Gómez-Puertas, Paulino
  • Ko, Jae-Kyun
  • Sarrió, David
  • Moreno-Bueno, Gema
Gasdermin (GSDM)-mediated pyroptosis is functionally involved in multiple diseases, but Gasdermin-B (GSDMB) exhibit cell death-dependent and independent activities in several pathologies including cancer. When the GSDMB pore-forming N-terminal domain is released by Granzyme-A cleavage, it provokes cancer cell death, but uncleaved GSDMB promotes multiple pro-tumoral effects (invasion, metastasis, and drug resistance). To uncover the mechanisms of GSDMB pyroptosis, here we determined the GSDMB regions essential for cell death and described for the first time a differential role of the four translated GSDMB isoforms (GSDMB1-4, that differ in the alternative usage of exons 6-7) in this process. Accordingly, we here prove that exon 6 translation is essential for GSDMB mediated pyroptosis, and therefore, GSDMB isoforms lacking this exon (GSDMB1-2) cannot provoke cancer cell death. Consistently, in breast carcinomas the expression of GSDMB2, and not exon 6-containing variants (GSDMB3-4), associates with unfavourable clinical-pathological parameters. Mechanistically, we show that GSDMB N-terminal constructs containing exon-6 provoke cell membrane lysis and a concomitant mitochondrial damage. Moreover, we have identified specific residues within exon 6 and other regions of the N-terminal domain that are important for GSDMB-triggered cell death as well as for mitochondrial impairment. Additionally, we demonstrated that GSDMB cleavage by specific proteases (Granzyme-A, Neutrophil Elastase and caspases) have different effects on pyroptosis regulation. Thus, immunocyte-derived Granzyme-A can cleave all GSDMB isoforms, but in only those containing exon 6, this processing results in pyroptosis induction. By contrast, the cleavage of GSDMB isoforms by Neutrophil Elastase or caspases produces short N-terminal fragments with no cytotoxic activity, thus suggesting that these proteases act as inhibitory mechanisms of pyroptosis. Summarizing, our results have important implications for understanding the complex roles of GSDMB isoforms in cancer or other pathologies and for the future design of GSDMB-targeted therapies., This study has been supported by the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MICINN-AEI, PID2019-104644RB-I00, PDC2022-133252-I00) -GMB-, (PID2021-126625OB-I00-MCIN/AEI/10.13039/501100011033 FEDER, EU.2022- and DTS20-00024 -ISCIII-) -PGP-, the Instituto de Salud Carlos III (CIBERONC, CB16/12/00295 -GMB- and CB16/12/00241 -JA-, and AC21_2/00020 ERA PerMed ERA-NET, PMP22/00054 Immune4ALL Personalized Medicine -GMB-, cofunded by NextGenerationEU), I “Semilla” CIBERONC-GEICAM Grant -GMB- and the AECC Scientific Foundation (FCAECC PROYE19036MOR and GCTRA18014MATI -GMB-), the National Institutes of Health (NIH, USA) (R01-DK123475) -J-KK- and it has been also supported by a startup fund to -J-KK- from the Ohio State University, the College of Medicine, Department of Surgery. DS contract is funded by CIBERONC partly supported by FEDER funds. SO is funded by the FCAECC (POSTD20028OLTR), SC is funded by the MICINN-AEI PRE2020-095658., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

STAG2: Computational Analysis of Missense Variants Involved in Disease

  • Ros-Pardo, David
  • Gómez-Puertas, Paulino
  • Marcos-Alcalde, Íñigo
The human STAG2 protein is an essential component of the cohesin complex involved in cellular processes of gene expression, DNA repair, and genomic integrity. Somatic mutations in the STAG2 sequence have been associated with various types of cancer, while congenital variants have been linked to developmental disorders such as Mullegama–Klein–Martinez syndrome, X-linked holoprosencephaly-13, and Cornelia de Lange syndrome. In the cohesin complex, the direct interaction of STAG2 with DNA and with NIPBL, RAD21, and CTCF proteins has been described. The function of STAG2 within the complex is still unknown, but it is related to its DNA binding capacity and is modulated by its binding to the other three proteins. Every missense variant described for STAG2 is located in regions involved in one of these interactions. In the present work, we model the structure of 12 missense variants described for STAG2, as well as two other variants of NIPBl and two of RAD21 located at STAG2 interaction zone, and then analyze their behavior through molecular dynamic simulations, comparing them with the same simulation of the wild-type protein. This will allow the effects of variants to be rationalized at the atomic level and provide clues as to how STAG2 functions in the cohesin complex., This research was financed by the following grants: Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MCIU-AEI, RTI2018-094434-B-I00 and PID2021-126625OB-I00/10.13039/501100011033/FEDER, EU), and Instituto de Salud Carlos III (DTS20-00024)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

In Silico Design of miniACE2 Decoys with In Vitro Enhanced Neutralization Activity against SARS-CoV-2, Encompassing Omicron Subvariants

  • Arévalo-Romero, Jenny Andrea
  • López-Cantillo, Gina
  • Moreno-Jiménez, Sara
  • Marcos-Alcalde, Íñigo
  • Ros-Pardo, David
  • Camacho, Bernardo Armando
  • Gómez-Puertas, Paulino
  • Ramírez-Segura, Cesar A.
The COVID-19 pandemic has overwhelmed healthcare systems and triggered global economic downturns. While vaccines have reduced the lethality rate of SARS-CoV-2 to 0.9% as of October 2024, the continuous evolution of variants remains a significant public health challenge. Next-generation medical therapies offer hope in addressing this threat, especially for immunocompromised individuals who experience prolonged infections and severe illnesses, contributing to viral evolution. These cases increase the risk of new variants emerging. This study explores miniACE2 decoys as a novel strategy to counteract SARS-CoV-2 variants. Using in silico design and molecular dynamics, blocking proteins (BPs) were developed with stronger binding affinity for the receptor-binding domain of multiple variants than naturally soluble human ACE2. The BPs were expressed in E. coli and tested in vitro, showing promising neutralizing effects. Notably, miniACE2 BP9 exhibited an average IC50 of 4.9 µg/mL across several variants, including the Wuhan strain, Mu, Omicron BA.1, and BA.2 This low IC50 demonstrates the potent neutralizing ability of BP9, indicating its efficacy at low concentrations.Based on these findings, BP9 has emerged as a promising therapeutic candidate for combating SARS-CoV-2 and its evolving variants, thereby positioning it as a potential emergency biopharmaceutical., This research was funded by Agencia Distrital de Educación Superior, Ciencia y Tecnología (ATENEA), Bogotá D.C., Colombia (Contract 057-2022, ID 9796). We also appreciate the fi-nancial support provided by the Pontificia Universidad Javeriana for J.A.A.-R. The P.G.-P. group (Í.M.-A. and D.R.-P.) at the CBM (CSIC-UAM) was supported by Spanish government grants RTI2018-094434-B-I00, PID2021-126625OB-I00 (MCIN/AEI-10.13039-501100011033-FEDER, EU.2022), and DTS20-00024 (ISCIII). We gratefully acknowledge the computational resources pro-vided by the Centro de Computación Científica (CCC-UAM). We also extend our sincere thanks to the National Health Institute of Colombia for their generous donation of the cPass kits., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

STAG2-RAD21 complex: A unidirectional DNA ratchet mechanism in loop extrusion

  • Ros-Pardo, David
  • Gómez-Puertas, Paulino
  • Marcos-Alcalde, Íñigo
This research was financed by the following grants: Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MCIU-AEI, RTI2018-094434-B-I00 and PID2021-126625OB-I00/10.13039/501100011033/FEDER, EU) and Instituto de Salud Carlos III (DTS20-00024).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The phenotypic and genotypic spectrum of individuals with mono- or biallelic ANK3 variants

  • Furia, Francesca
  • Levy, Amanda M.
  • Theunis, Miel
  • Bamshad, Michael J.
  • Bartos, Meghan N.
  • Bijlsma, Emilia K.
  • Brancati, Francesco
  • Cejudo, Lucile
  • Chong, Jessica X.
  • De Luca, Chiara
  • Dean, Sarah Joy
  • Egense, Alena
  • Goel, Himanshu
  • Guenzel, Adam J.
  • Hüffmeier, Ulrike
  • Legius, Eric
  • Mancini, Grazia M. S.
  • Marcos-Alcalde, Iñigo
  • Niclass, Tanguy
  • Planes, Marc
  • Redon, Sylvia
  • Ros-Pardo, David
  • Rouault, Karen
  • Schot, Rachel
  • Schuhmann, Sarah
  • Shen, Joseph J.
  • Tao, Alice M
  • Thiffault, Isabelle
  • Van Esch, Hilde
  • Wentzensen, Ingrid M.
  • Barakat, Tahsin Stefan
  • Møller, Rikke S.
  • Gómez-Puertas, Paulino
  • Chung, Wendy K.
  • Gardella, Elena
  • Tümer, Zeynep
NHGRI, Grant/Award Numbers: U01HG011744, U24 HG011746; Netherlands Organisation for Scientific Research, Grant/Award Number: 09150172110002; Italian Ministry of Health; Italian Ministry of University and Research, Grant/Award Numbers: PRIN2022, PRIN PNRR 2022; P50HD109879; Spanish Government, Grant/Award Numbers: RTI2018-094434-BI00, PID2021-126625OB-I00
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An engineered miniACE2 protein secreted by mesenchymal stromal cells effectively neutralizes multiple SARS-CoV- 2 variants in vitro

  • Moreno-Jiménez, Sara
  • López-Cantillo, Gina
  • Arevalo-Romero, Jenny Andrea
  • Perdomo-Arciniegas, Ana María
  • Moreno-Gonzalez, Andrea Marisol
  • Devia-Mejia, Bellaneth
  • Camacho, Bernardo Armando
  • Gómez-Puertas, Paulino
  • Ramirez-Segura, Cesar A.
SARS-CoV- 2 continues to evolve, producing novel Omicron subvariants through recombinant lineages that acquire new mutations, undermining existing antiviral strategies. The viral fitness and adaptive potential of SARS-CoV- 2 present significant challenges to emergency treatments, particularly monoclonal antibodies, which demonstrate reduced efficacy with the emergence of each new variant. Consequently, immunocompromised individuals, who are more susceptible to severe manifestations of COVID- 19 and face heightened risks of critical complications and mortality, remain vulnerable in the absence of effective emergency treatments. To develop translational approaches that can benefit this at-risk population and establish broader therapeutic strategies applicable across variants, we previously designed and engineered in silico miniACE2 decoys (designated BP2, BP9, and BP11). These decoys demonstrated promising efficacy in neutralizing Omicron subvariants. In this study, we leveraged the therapeutic potential of mesenchymal stromal cells (MSCs) for tissue repair and immunomodulation in lung injuries and used these cells as a platform for the secretion of BP2. Our innovative assays, which were conducted with the BP2 protein secreted into the culture supernatant of BP2-MSCs, demonstrated the potential for neutralizing SARS-CoV- 2, including Omicron subvariants. The development of these advanced therapeutic platforms holds significant promise for scalability to effectively mitigate the impact of severe COVID- 19, contributing to broader and more resilient treatment strategies against the evolving landscape of SARS-CoV- 2 variants., This research was financially supported by Agencia Distrital de Educación Superior, Ciencia y Tecnología (ATENEA), Bogotá D.C., Colombia (Contract 057 - 2022, ID 9796). The PGP group at the CBM (CSIC-UAM) was supported by Spanish Government grants RTI2018 - 094434-B-I00, PID2021 - 126625OB-I00 (MCIN/AEI- 10.13039 - 501100011033-FEDER, EU.2022 and DTS20 - 00024 (ISCIII) and gratefully recognizes the computational support of Centro de Computación Científica CCC-UAM. The authors gratefully acknowledge the funding support for C.A.R.-S. and G.L.-C. and S.M.-J. provided by Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud (IDCBIS), through resources transferred from Fondo Financiero Distrital de Salud (FFDS) to IDCBIS (Resolution 409, 2024, issued by the District Health Secretariat)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ligand–Enzyme Interaction Modeling of Missense Variants Implicated in Mitochondrial HMG-CoA Synthase Deficiency

  • Arnedo, María
  • Ros-Pardo, David
  • Puisac, Beatriz
  • Lucia-Campos, Cristina
  • Gil-Salvador, Marta
  • Latorre-Pellicer, Ana
  • Marcos-Alcalde, Íñigo
  • Pié, Juan
  • Gómez-Puertas, Paulino
This article belongs to the Section Biochemistry., Human mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (HMG-CoA synthase, mHS) synthase is a key enzyme in ketogenesis and is located mainly in the liver, but also in the colon, skeletal muscle, heart, pancreas, and testes. It is an inner mitochondrial membrane-associated protein. Mutations in the HMGCS2 gene, which encodes this enzyme, lead to “mHS deficiency,” a rare, autosomal recessive, inherited metabolic disorder. To date, about 100 patients with this disorder have been described. The disorder usually appears during the first year of life, often after a period of starvation or an intercurrent illness. A total of 77 different DNA mutations has been described that are considered responsible for mHS deficiency, although the mechanisms leading to loss of function are not fully understood. To study how the different missense variants affect the enzymatic activity of the protein on an atomic scale, we used molecular dynamics computational simulation techniques for variants whose activity could be measured “in vitro.” The study included a total of 46 molecular dynamics trajectories of enzyme–substrate/product interaction simulations, each 500 ns long (23 microseconds total). Currently, the atomic and biophysical effects of the mHS variants on their catalyzed reactions have not been studied in detail experimentally. To our knowledge, molecular dynamics simulations are one of the most promising tools for understanding the molecular basis of the phenotypic consequences of these variants. In the present work, molecular dynamics simulations reliably reproduce most experimental enzyme activity measurements, supporting their future application to the study of new mHS mutations., This research was financed by the following grants: Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (PID2021-126625OB-I00/10.13039/501100011033/ FEDER, EU) to P.G-P. and Diputación General de Aragón-FEDER: European Social Fund (Reference Group B32_20R) to J.P., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

ROGDI-Related Disorder Resulting from Disruption of Complex Interactive Neuro-Dental Developmental Networks: A Review and Description of the First Missense Variant

  • Gverdtsiteli, Sopio
  • Hammer, Trine B.
  • Hermann, Xenia
  • Andersen, Noemi Becser
  • Ros-Pardo, David
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Brook, Alan Henry
  • Silahtaroglu, Asli
  • Tümer, Zeynep
ROGDI-related neurodevelopmental and dental disorder (ROGDI-RD), also known as Kohlschütter–Tönz syndrome (KTZS, MIM #226750), is a rare condition characterized by developmental abnormalities affecting both the central nervous system (CNS) and the dentition. These phenotypes highlight the role of complex gene–environment interactions and developmental networks shared by the nervous and stomatognathic systems, both of which originate mostly from neural crest-derived cells. In this review, we analyze clinical and genetic data from 54 previously reported ROGDI-RD patients to better define the phenotypic spectrum of the disorder. Most of the reported cases harbor protein-truncating variants. Here, we also present the first description of a patient carrying a missense variant in ROGDI atypical leucine zipper gene, ROGDI in trans to a frameshift variant. This individual presented with tooth agenesis—a dental anomaly not previously associated with the syndrome—alongside classic neurological and dental enamel features, suggesting that the phenotypic spectrum of ROGDI-RD may be broader than currently recognized. Using a complexity and network science framework, we discuss how dysregulation in multilevel, interacting developmental systems may explain the pleiotropic features of ROGDI-RD. Our findings underscore the importance of early, interdisciplinary clinical evaluation in patients with neurodevelopmental symptoms and enamel defects. As enamel phenotypes such as amelogenesis imperfecta are heterogeneous, comprehensive genomic analyses and collaborative clinical approaches are essential for accurate diagnosis and improved care., This work was supported partially by Spanish government grant PID2021-126625OB-I00 (MCIN/AEI/10.13039/501100011033/FEDER,EU.2022) to P.G.-P. ERN-ITHACA is funded by the European Union, under the grant agreement N°101156387., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Postzygotic mosaicism in SMC1A and the first reported case of a female with Cornelia de Lange syndrome

  • Gil-Salvador, Marta
  • Trujillano, Laura
  • Lucia-Campos, Cristina
  • Del Rincón, Julia
  • Arnedo, María
  • Puisac, Beatriz
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Ramos, Feliciano J.
  • Pié, Juan
  • Latorre-Pellicer, Ana
  • Pamplona, Pilar
Postzygotic mosaicism (PZM) has been increasingly recognized in Cornelia de Lange syndrome (CdLS). However, it has been scarcely described when the genetic cause resides in SMC1A, an X-linked cohesin member implicated in approximately 5% of cases. Here, we report the first female patient with classic CdLS harboring a PZM variant in SMC1A and provide a comprehensive characterization of mosaicism in this gene. The identified PZM variant [SMC1A:NM_006306.3:c.2369 = /G > A; p.(Arg790Gln)], was detected in blood and buccal swab-derived DNA at around 30% allele frequency. Molecular dynamics simulations suggest that this mutation disrupts the elbow domain of SMC1A, potentially impairing cohesin function. Further delineation of phenotypes and genotypes associated with PZM variants in SMC1A reveals that, similar to constitutive variants, mosaic mutations are predominantly missense and distributed throughout the gene. Moreover, the phenotype of patients carrying mosaic variants is clinically indistinguishable from those with constitutive mutations, and purifying selection of the pathogenic variant in blood is suggested, as previously observed in NIPBL-related CdLS. However, this process may be more complex in SMC1A due to its X-linked nature. Our findings underscore the importance of high-sensitivity sequencing techniques for detecting mosaicism and highlight the complexity of X-linked mosaic variants in disease expressivity. Further functional studies and larger cohorts are crucial to improve genotype–phenotype correlations and diagnostics in CdLS., The funding was provided by Spanish Ministry of Health-ISCIII, PI23/01370; Spanish Government grant, PID2021-126625OB-I00; Diputación General de Aragón-FEDER: European Social Fund, B32_20R; University of Zaragoza, JIUZ2023-SAL-06.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

HCN4 Mutation Causing Familial Inappropriate Sinus Tachycardia Leads to a Conformational Change Mimicking cAMP Binding and Induces Constitutive Channel Activity

  • Bober, Sara L.
  • Li, Qiuju
  • Ros-Pardo, David
  • Faultless, Trent
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Gollob, Michael H.
BACKGROUND: Inappropriate sinus tachycardia (IST) is an arrhythmia characterized by rapid sinus rates of over 100 bpm at rest. The mechanisms underlying this often-debilitating condition are not fully understood. The differential diagnosis for this persistent observation is broad, including medication side effects or serendipitous use of chronotropic stimulating drugs. Genetic causes of IST are seldom considered. Only 2 mutations have been linked to this condition, both of which affect the gene encoding HCN4 channels, which play an important role in generating pacemaker activity of the sinoatrial node. METHODS: Standard clinical genetic testing was performed on a child with IST, her affected mother, and 2 healthy siblings. A novel HCN4 channel variant identified in the family was studied by whole-cell patch clamp analysis. Three-dimensional protein structures of mutant and wild-type HCN4 channels were generated and subjected to 200 ns of unrestricted molecular dynamics simulation. RESULTS: A heterozygous, missense variant was identified in the HCN4 gene (p.N299S) in the affected child and mother, while absent in 2 healthy siblings of the child. Patch clamp analysis revealed significantly increased HCN4 current density and a rightward-shifted activation curve in cells expressing p.N299S-HCN4 versus wild-type channels, suggesting constitutive activity of the mutant HCN4 channel. In molecular dynamics simulations, the voltage sensor of p.N299S-HCN4 channels adopted a resting conformation mimicking that of cAMP-bound wild-type HCN4, providing a structural basis for the functional observations. Ivabradine application returned the gain-of-function properties of mutant channels to baseline levels. CONCLUSIONS: We identified a gain-of-function HCN4 variant in a family with IST that displays constitutive activity and structurally mimics the effects of cAMP activation. This study furthers our understanding of the mechanisms underlying IST and provides data supporting the efficacious effect of ivabradine in genetically based IST., This work was supported by a grant from the Canadian Institutes for Health Research (408226) to Dr Gollob, and a Spanish Government grant PID2021-126625OB-I00 (MCIN/AEI/10.13039/501100011033/FEDER,EU.2022) to Dr Gómez-Puertas. Dr Gollob is further supported by the Ian Copland Arrhythmia and Sudden Death Research Fund, University of Toronto.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

De novo genome assembly and annotation of Gnathostoma spinigerum

  • González-Bertolín, Belén
  • Monzón, Sara
  • Zaballos, Ángel
  • Jiménez, Pilar
  • Dekumyoy, Paron
  • Adisakwattana, Poom
  • Varona, Sarai
  • Cuesta, Isabel
  • Sumanam, Sunita B.
  • Sotillo, Javier
  • Hernández-González, Ana
  • Marcos-Alcalde, Iñigo
  • Gómez-Puertas, Paulino
  • Young, Neil D.
  • Perteguer, Maria J.
Background: Gnathostoma spinigerum is a parasitic nematode implicated in human cases of eosinophilic meningitis. This species is primarily endemic to Thailand and frequently occurs in other regions as imported cases. Although this parasite poses a significant pathogenic risk, its genome has not yet been assembled or annotated. The aim of our study is to generate the first genome assembly of G. spinigerum. Methods: Whole-genome sequence libraries were generated from genomic DNA extracted from a pooled sample of advanced stage 3 larvae. After sequencing, the assembly of the genome was produced using a combination of second- and third-generation sequencing technologies. Multiple draft assemblies were generated and evaluated, and the absence of contamination was determined. Identification and modeling of new G. spinigerum metalloproteinases and tissue inhibitors of metalloproteinases were performed, and molecular dynamics simulations were used to analyze their potential interactions. The final assembly was annotated and made publicly available via the NCBI genome database. Results: The hybrid assembly approach (using short and long reads) using the SPAdes assembler and with post-assembly polishing (Pilon/Picard) yielded the most complete genome (222-Mb genome size, N50 = 14,149 bp, 69.6% BUSCO assembly). A total of 14,451 protein-coding genes were predicted in the G. spinigerum genome with 62.3% BUSCO annotation completeness. Three-dimensional computational modeling and molecular dynamics of six new metalloproteinases and two new tissue inhibitors of metalloproteinases are presented. Conclusions: We provide the first sequence assembly and annotation for the nematode G. spinigerum. This draft genome will be an essential resource for future scientific and applied investigations of diseases caused by this parasite., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This study was funded by Instituto de Salud Carlos III (AESI-PI22CIII/00010) and by CIBERINFEC-UE-(CB21/13/00120) to MJP and AEI (PID2021-126625OB-I00) to PGP. BGB received a Predoctoral Fellowship award for career development by Fundación Rafael Folch (2021/E02) and a mobility grant from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). The funders had no role in study design, data collection and analysis, decision or publish, or preparation of the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Expanding the ABCA2-associated neurodevelopmental phenotype

  • Oja, Kaisa T.
  • Reinson, Karit
  • Ilisson, Mihkel
  • Örd, Daima
  • Wojcik, Monica H.
  • Seaby, Eleanor G.
  • Wittmann, Bryan M.
  • Kennedy, Adam D.
  • DeBalsi, Karen
  • Zweier, Christiane
  • Vasileiou, Georgia
  • Alkhawaja, Issam A.
  • Wirth, Thomas
  • Syrbe, Steffen
  • Platzer, Konrad
  • Alyamani, Suad
  • Alkuraya, Fowzan S.
  • Ros-Pardo, David
  • Marcos-Alcalde, Iñigo
  • Gómez-Puertas, Paulino
  • Vidailhet, Marie
  • Su, Ke
  • Fan, Shaohua
  • Ma, Yu
  • Wang, Yi
  • Renieri, Alessandra
  • Pinto, Anna Maria
  • Almadhoun, Farah
  • Petersen, Andrea K.
  • Magnussen, Kari
  • Bodamer, Olaf
  • Alanzi, Talal
  • Mohamed, Sarar
  • Alrabee, Hadeel
  • Alhaddad, Bader
  • Bakur, Khadijah
  • Fleischer, Nicole
  • Begtrup, Amber
  • Örd, Tõnis
  • Pajusalu, Sander
  • Õunap, Katrin
The ATP-binding cassette subfamily A member 2 ( ABCA2 ) gene encodes an ABC transporter protein. Bi-allelic loss-of-function variants in ABCA2 have been associated with an intellectual disability disorder. We aimed to delineate the phenotypic spectrum of individuals with monoallelic (MV) or bi-allelic (BV) variants in the ABCA2 gene. We collected clinical data via questionnaires and literature review. The ABCA2 protein was constructed using homology modeling. Untargeted plasma metabolomics was performed at Metabolon. A docetaxel toxicity cell culture model system was used to study the effects of plasmid-encoded ABCA2 and four ABCA2 variants (p.Asp615Glu [c.1845C>A], p.Phe754Ser [c.2261T>C], p.Ile786del [c.2356_2358del], and p.Arg926Trp [c.2776C>T]) on cell viability. Seventeen individuals with seventeen candidate ABCA2 variants were identified (seven MVs and ten BVs). Protein modeling predicted a likely significant impact for eight of 13 assessed variants. In cell viability assays, enforced expression of wild-type ABCA2 reduced viability in docetaxel-exposed cells. In contrast, none of the four variants affected viability, suggesting a loss or a marked reduction in transporter function. Untargeted metabolomics of three samples from two individuals showed a trend toward lower levels of polyunsaturated acylcarnitines. This study describes 17 individuals with candidate variants in the ABCA2 gene. The cell viability assays revealed that four variants (p.Asp615Glu, p.Phe754Ser, p.Ile786del, and p.Arg926Trp) had an altered ability to function as a transporter compared to wild-type ABCA2. Further studies are needed to clarify the pathomechanism of ABCA2 and the clinical significance of the variants., This work is supported by Estonian Research Council grants PUT355, PRG471, PRG2040, PRG1475, and PSG774; the Broad Institute Center for Mendelian Genomics (UM1HG008900) is funded by the National Human Genome Research Institute (NHGRI) with supplemental funding provided by the National Heart, Lung, and Blood Institute and the National Eye Institute (sequencing and analysis), and NHGRI grants U01HG011755 and R01HG009141 (analysis). M.H.W. is supported by NIH/NICHD K23HD102589. This work was also supported by Spanish government grants RTI2018-094434-B-I00, PID2021-126625OB-I00 (MCIN/AEI/10.13039/501100011033/ FEDER,EU.2022), and DTS20-00024 (ISCIII) to P.G.-P., as well as funds from the European JPIAMR network “EPIC-Alliance” to P.G.-P. The computational support of the “Centro de Computación Científica CCC-UAM” is gratefully recognized. A.R. and A.M.P. received funding from GENERA FSC 2014–2020 - Genoma medicina personalizzata - POS-Ministero della Salute T3-AN-04 to A.R.; EU H2020-SC1-FA-DTS-2018–2020, International Consortium for Integrative Genomics Prediction - grant agreement no. 101016775 to A.R.; and ERDERA Diagnostic Research Workstream to A.R.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Postzygotic mosaicism in SMC1A and the first reported case of a female with Cornelia de Lange syndrome

  • Gil-Salvador, Marta
  • Trujillano, Laura
  • Lucia-Campos, Cristina
  • Del Rincón, Julia
  • Pamplona, Pilar
  • Arnedo, María
  • Puisac, Beatriz
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Ramos, Feliciano J.
  • Pié, Juan
  • Latorre-Pellicer, Ana
Postzygotic mosaicism (PZM) has been increasingly recognized in Cornelia de Lange syndrome (CdLS). However, it has been scarcely described when the genetic cause resides in SMC1A, an X-linked cohesin member implicated in approximately 5% of cases. Here, we report the first female patient with classic CdLS harboring a PZM variant in SMC1A and provide a comprehensive characterization of mosaicism in this gene. The identified PZM variant [SMC1A:NM_006306.3:c.2369 = /G > A; p.(Arg790Gln)], was detected in blood and buccal swab-derived DNA at around 30% allele frequency. Molecular dynamics simulations suggest that this mutation disrupts the elbow domain of SMC1A, potentially impairing cohesin function. Further delineation of phenotypes and genotypes associated with PZM variants in SMC1A reveals that, similar to constitutive variants, mosaic mutations are predominantly missense and distributed throughout the gene. Moreover, the phenotype of patients carrying mosaic variants is clinically indistinguishable from those with constitutive mutations, and purifying selection of the pathogenic variant in blood is suggested, as previously observed in NIPBL-related CdLS. However, this process may be more complex in SMC1A due to its X-linked nature. Our findings underscore the importance of high-sensitivity sequencing techniques for detecting mosaicism and highlight the complexity of X-linked mosaic variants in disease expressivity. Further functional studies and larger cohorts are crucial to improve genotype–phenotype correlations and diagnostics in CdLS.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Ligand–Enzyme Interaction Modeling of Missense Variants Implicated in Mitochondrial HMG-CoA Synthase Deficiency

  • Arnedo, María
  • Ros-Pardo, David
  • Puisac, Beatriz
  • Lucia-Campos, Cristina
  • Gil-Salvador, Marta
  • Latorre-Pellicer, Ana
  • Marcos-Alcalde, Íñigo
  • Pié, Juan
  • Gómez-Puertas, Paulino
Human mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase (HMG-CoA synthase, mHS) synthase is a key enzyme in ketogenesis and is located mainly in the liver, but also in the colon, skeletal muscle, heart, pancreas, and testes. It is an inner mitochondrial membrane-associated protein. Mutations in the HMGCS2 gene, which encodes this enzyme, lead to “mHS deficiency,” a rare, autosomal recessive, inherited metabolic disorder. To date, about 100 patients with this disorder have been described. The disorder usually appears during the first year of life, often after a period of starvation or an intercurrent illness. A total of 77 different DNA mutations has been described that are considered responsible for mHS deficiency, although the mechanisms leading to loss of function are not fully understood. To study how the different missense variants affect the enzymatic activity of the protein on an atomic scale, we used molecular dynamics computational simulation techniques for variants whose activity could be measured “in vitro.” The study included a total of 46 molecular dynamics trajectories of enzyme–substrate/product interaction simulations, each 500 ns long (23 microseconds total). Currently, the atomic and biophysical effects of the mHS variants on their catalyzed reactions have not been studied in detail experimentally. To our knowledge, molecular dynamics simulations are one of the most promising tools for understanding the molecular basis of the phenotypic consequences of these variants. In the present work, molecular dynamics simulations reliably reproduce most experimental enzyme activity measurements, supporting their future application to the study of new mHS mutations.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

  • Oltra Sanchis, Sara
  • Albanell Mestres, Joan
  • Moreno-Bueno, Gema
Gasdermin (GSDM)-mediated pyroptosis is functionally involved in multiple diseases, but Gasdermin-B (GSDMB) exhibit cell death-dependent and independent activities in several pathologies including cancer. When the GSDMB pore-forming N-terminal domain is released by Granzyme-A cleavage, it provokes cancer cell death, but uncleaved GSDMB promotes multiple pro-tumoral effects (invasion, metastasis, and drug resistance). To uncover the mechanisms of GSDMB pyroptosis, here we determined the GSDMB regions essential for cell death and described for the first time a differential role of the four translated GSDMB isoforms (GSDMB1-4, that differ in the alternative usage of exons 6-7) in this process. Accordingly, we here prove that exon 6 translation is essential for GSDMB mediated pyroptosis, and therefore, GSDMB isoforms lacking this exon (GSDMB1-2) cannot provoke cancer cell death. Consistently, in breast carcinomas the expression of GSDMB2, and not exon 6-containing variants (GSDMB3-4), associates with unfavourable clinical-pathological parameters. Mechanistically, we show that GSDMB N-terminal constructs containing exon-6 provoke cell membrane lysis and a concomitant mitochondrial damage. Moreover, we have identified specific residues within exon 6 and other regions of the N-terminal domain that are important for GSDMB-triggered cell death as well as for mitochondrial impairment. Additionally, we demonstrated that GSDMB cleavage by specific proteases (Granzyme-A, Neutrophil Elastase and caspases) have different effects on pyroptosis regulation. Thus, immunocyte-derived Granzyme-A can cleave all GSDMB isoforms, but in only those containing exon 6, this processing results in pyroptosis induction. By contrast, the cleavage of GSDMB isoforms by Neutrophil Elastase or caspases produces short N-terminal fragments with no cytotoxic activity, thus suggesting that these proteases act as inhibitory mechanisms of pyroptosis. Summarizing, our results have important implications for understanding the complex roles of GSDMB isoforms in cancer or other pathologies and for the future design of GSDMB-targeted therapies., This study has been supported by the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MICINN-AEI, PID2019-104644RB-I00, PDC2022-133252-I00) -GMB-, (PID2021-126625OB-I00-MCIN/AEI/10.13039/501100011033 FEDER, EU.2022- and DTS20-00024 -ISCIII-) -PGP-, the Instituto de Salud Carlos III (CIBERONC, CB16/12/00295 -GMB- and CB16/12/00241 -JA-, and AC21_2/00020 ERA PerMed ERA-NET, PMP22/00054 Immune4ALL Personalized Medicine -GMB-, cofunded by NextGenerationEU), I “Semilla” CIBERONC-GEICAM Grant -GMB- and the AECC Scientific Foundation (FCAECC PROYE19036MOR and GCTRA18014MATI -GMB-), the National Institutes of Health (NIH, USA) (R01-DK123475) -J-KK- and it has been also supported by a startup fund to -J-KK- from the Ohio State University, the College of Medicine, Department of Surgery. DS contract is funded by CIBERONC partly supported by FEDER funds. SO is funded by the FCAECC (POSTD20028OLTR), SC is funded by the MICINN-AEI PRE2020-095658.